Boyar WC - Search Results

1

Cook WJ, Galakatos N, Boyar WC, Walter RL, Ealick SE. Cook WJ, et al. Among authors: boyar wc. Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):190-7. doi: 10.1107/S0907444909049051. Epub 2010 Jan 22. Acta Crystallogr D Biol Crystallogr. 2010. PMID: 20124699

2

Characterization of human PLD2 and the analysis of PLD isoform splice variants.

Steed PM, Clark KL, Boyar WC, Lasala DJ. Steed PM, et al. Among authors: boyar wc. FASEB J. 1998 Oct;12(13):1309-17. doi: 10.1096/fasebj.12.13.1309. FASEB J. 1998. PMID: 9761774

3

Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin.

Chen Z, Zhang X, Gonnella NC, Pellas TC, Boyar WC, Ni F. Chen Z, et al. Among authors: boyar wc. J Biol Chem. 1998 Apr 24;273(17):10411-9. doi: 10.1074/jbc.273.17.10411. J Biol Chem. 1998. PMID: 9553099 Free article.

4

Analysis of hydroperoxide-induced tyrosyl radicals and lipoxygenase activity in aspirin-treated human prostaglandin H synthase-2.

Xiao G, Tsai AL, Palmer G, Boyar WC, Marshall PJ, Kulmacz RJ. Xiao G, et al. Among authors: boyar wc. Biochemistry. 1997 Feb 18;36(7):1836-45. doi: 10.1021/bi962476u. Biochemistry. 1997. PMID: 9048568

5

The pharmacophore of the human C5a anaphylatoxin.

Toth MJ, Huwyler L, Boyar WC, Braunwalder AF, Yarwood D, Hadala J, Haston WO, Sills MA, Seligmann B, Galakatos N. Toth MJ, et al. Among authors: boyar wc. Protein Sci. 1994 Aug;3(8):1159-68. doi: 10.1002/pro.5560030802. Protein Sci. 1994. PMID: 7987211 Free PMC article.

6

Discriminatory roles for D1 and D2 dopamine receptor subtypes in the in vivo control of neostriatal cyclic GMP.

Altar CA, Boyar WC, Kim HS. Altar CA, et al. Among authors: boyar wc. Eur J Pharmacol. 1990 May 31;181(1-2):17-21. doi: 10.1016/0014-2999(90)90240-7. Eur J Pharmacol. 1990. PMID: 1974856

7

Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin.

Altar CA, Boyar WC. Altar CA, et al. Among authors: boyar wc. Brain Res. 1989 Apr 3;483(2):321-6. doi: 10.1016/0006-8993(89)90176-5. Brain Res. 1989. PMID: 2706523

8

Inhibition of nigrostriatal release of dopamine in the rat by adenosine receptor agonists: A1 receptor mediation.

Wood PL, Kim HS, Boyar WC, Hutchison A. Wood PL, et al. Among authors: boyar wc. Neuropharmacology. 1989 Jan;28(1):21-5. doi: 10.1016/0028-3908(89)90062-2. Neuropharmacology. 1989. PMID: 2538767

9

Cholecystokinin attenuates basal and drug-induced increases of limbic and striatal dopamine release.

Altar CA, Boyar WC, Oei E, Wood PL. Altar CA, et al. Among authors: boyar wc. Brain Res. 1988 Sep 13;460(1):76-82. doi: 10.1016/0006-8993(88)90431-3. Brain Res. 1988. PMID: 3219572

10

Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonists.

Altar CA, Boyar WC, Wasley A, Gerhardt SC, Liebman JM, Wood PL. Altar CA, et al. Among authors: boyar wc. Naunyn Schmiedebergs Arch Pharmacol. 1988 Aug;338(2):162-8. doi: 10.1007/BF00174864. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 2903451

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page